Literature DB >> 1972991

Ultrastructural localization of dystrophin in human muscle by using gold immunolabelling.

M J Cullen1, J Walsh, L V Nicholson, J B Harris.   

Abstract

Immunolabelling with a 5 nm gold probe was used to localize dystrophin at the ultrastructural level in human muscle. The primary antibody was monoclonal, raised against a segment (amino acids 1181-1388) from the rod domain of dystrophin. The antibody (Dy4/6D3) is specific for dystrophin and shows no immunoreactivity with any protein from mdx mouse muscle or from patients with a gene deletion spanning part of the molecule recognized by the antibody (Nicholson et al. 1989 a; England et al. 1990). Using this antibody, labelling was almost entirely confined to a narrow 75 nm rim at the periphery of the muscle fibres. Histograms of the distance from the gold probe to the cytoplasmic face of the plasma membrane and of the distance between gold probes (nearest neighbour in a plane parallel with the plasma membrane) displayed modes at approximately 15 nm and 120 nm, respectively. The distribution of the probe was the same in longitudinal and transverse sections of the muscle. These observations suggest that the rod portion of the dystrophin molecule is normally arranged close to the cytoplasmic face of the plasma membrane and that the molecules form an interconnecting network. Labelling was not associated with the transverse tubular system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972991     DOI: 10.1098/rspb.1990.0034

Source DB:  PubMed          Journal:  Proc R Soc Lond B Biol Sci        ISSN: 0950-1193


  35 in total

Review 1.  Recent advances in understanding muscular dystrophy.

Authors:  K M Bushby
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

2.  Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers.

Authors:  C J Klein; D D Coovert; D E Bulman; P N Ray; J R Mendell; A H Burghes
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

Review 3.  Proteomic profiling of x-linked muscular dystrophy.

Authors:  Caroline Lewis; Steven Carberry; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2009-12       Impact factor: 2.698

4.  Filamentous structures in skeletal muscle: anchors for the subsarcolemmal space.

Authors:  Astrid Feinisa Khairani; Yuki Tajika; Maiko Takahashi; Hitoshi Ueno; Tohru Murakami; Arifin Soenggono; Hiroshi Yorifuji
Journal:  Med Mol Morphol       Date:  2014-02-12       Impact factor: 2.309

5.  Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle.

Authors:  D J Law; J G Tidball
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

Review 6.  The membrane hypothesis of Duchenne muscular dystrophy: quest for functional evidence.

Authors:  O F Hutter
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

7.  Localisation and characterisation of dystrophin in the central nervous system of controls and patients with Duchenne muscular dystrophy.

Authors:  M Uchino; H Teramoto; H Naoe; K Yoshioka; T Miike; M Ando
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

8.  Localization of dystrophin and beta-spectrin in vacuolar myopathies.

Authors:  J L De Bleecker; A G Engel; J C Winkelmann
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

9.  Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch.

Authors:  P Moens; P H Baatsen; G Maréchal
Journal:  J Muscle Res Cell Motil       Date:  1993-08       Impact factor: 2.698

10.  Xp21 dystrophin and 6q dystrophin-related protein. Comparative immunolocalization using multiple antibodies.

Authors:  T Voit; K Haas; J O Léger; F Pons; J J Léger
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.